1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Taiyo Service Inc. has 1 pending office action. The record identifies 1 distinct examiner and 0 distinct art units, so the available assignment data does not identify an art-unit allocation for the matter.
LANDSMAN, ROBERT S is the busiest examiner for the pending work. Counsel can focus immediate review on that examiner while recognizing that the technical classification information is not specified.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANDSMAN, ROBERT S | 1 | 81.4% | +13.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702620 | ANTICANCER AGENT, PRODRUG OF ANTICANCER AGENT, METHOD FOR KILLING CANCER CELL IN VITRO, CANCER TREATEMENT METHOD, AND CANCER TREATMENT DEVICE | LANDSMAN, ROBERT S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702620 | ANTICANCER AGENT, PRODRUG OF ANTICANCER AGENT, METHOD FOR KILLING CANCER CELL IN VITRO, CANCER TREATEMENT METHOD, AND CANCER TREATMENT DEVICE | LANDSMAN, ROBERT S | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18702620 | ANTICANCER AGENT, PRODRUG OF ANTICANCER AGENT, METHOD FOR KILLING CANCER CELL IN VITRO, CANCER TREATEMENT METHOD, AND CANCER TREATMENT DEVICE | LANDSMAN, ROBERT S | — | §112 | Non-Final OA | — | Pending | Apr 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTaiyo Service Inc. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Robert S Landsman has the most, with 1 of Taiyo Service Inc.'s pending office actions.
